A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Caribou Biosciences Inc’s current trading price is -37.66% away from its 52-week high, while its distance from the 52-week low is 183.33%. The stock’s price range for this time frame has been between $0.66 and $3.00. The trading volume of the company’s shares in the Healthcare reached around 1.37 million for the day, which was evidently lower than the average daily volume of 1.61 million over the last three months.
Caribou Biosciences Inc (CRBU) current stock price is $1.87. During the last trading session, the stock soared, reaching $32.0 after opening at $1.87. The stock’s lowest point was $1.0 before it closed at $1.98.
The stock market performance of Caribou Biosciences Inc has been very steady. Over the last year, the company’s stock hit its highest at $3.00 on 11/07/24, while the lowest price during the same time frame was $0.66, recorded on 04/07/25.
How Financial Performance Impacts Market Capitalization
Caribou Biosciences Inc (CRBU) has experienced a quarterly rise of 99.28% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 174.14M and boasts a workforce of 147 employees.
Decoding Analysts’ Ratings for Caribou Biosciences Inc
As of right now, 5 analysts are rating Caribou Biosciences Inc as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.2851, with a change in price of +0.9096. Similarly, Caribou Biosciences Inc recorded 1,405,625 in trading volume during the last 100 days, posting a change of +94.71%.
How CRBU’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for CRBU stands at 0.16. Similarly, the long-term debt-to-equity ratio is also 0.14.
CRBU Stock Stochastic Average
Caribou Biosciences Inc’s raw stochastic average for the past 50 days is currently at 51.23%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 24.02%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 31.71% and 31.21%, respectively.
CRBU Stock Price Performance Analysis
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Until today this year the stock’s price performance recorded a decrease of -1.58%. However, over the last six months, the performance has been weaker by 38.52%. The price of CRBU decreased -8.78% over the last 30 days. And in the last five days, it has surged by 9.36%.
